Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial

Overview of attention for article published in Lancet Neurology, January 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

news: 14 news outlets
blogs: 1 blog
twitter: 17 X users
facebook: 2 Facebook pages

reddit: 2 Redditors
guideline: 5 clinical guideline sources
podcasts: 4 podcasts

Readers on

mendeley: 266 Mendeley

So far, Altmetric has seen 5 Guidelines that reference this research output.

Taiwan Clinical Practice Guidelines for Myasthenia Gravis.

Clinical guideline published by Taiwan Neurological Society (TNS) on 24 Apr 2026

The Taiwan Neurological Society (TNS), founded in 1983, is the primary professional organization for neurologists in Taiwan.

Generalized myasthenia gravis with acetylcholine receptorantibodies: A guidance for treatment

Clinical guideline published by Danish Rehabilitation Centre for Neuromuscular Diseases (RCFM) on 06 Feb 2024

The Danish Rehabilitation Centre for Neuromuscular Diseases (RCFM) is a center of excellence for neuromuscular diseases.

Guideline for the management of myasthenic syndromes

Clinical guideline published by Deutsche Gesellschaft für Neurologie e. V. (DGN) on 26 Dec 2023

The Deutsche Gesellschaft für Neurologie e. V. (DGN) is a prominent organization dedicated to advancing neurology in Germany. It focuses on promoting research, education, and clinical practice guidelines to enhance patient care and support neurologists in their professional development.

Miastenia Gravis

Clinical guideline published by Comissão Nacional de Incorporação de Tecnologias no Sistema Único de Saúde - CONITEC on 27 May 2022

Conitec is a permanent collegiate body, part of the regulatory structure of the Ministry of Health, and its objective is to advise the Ministry of Health on tasks related to the incorporation, exclusion or alteration of health technologies by the SUS, as well as the creation or alteration of clinical protocols and therapeutic guidelines.

This page shows the most recent posts that mention this research output. Click here to find out how to access more activity, including 1 additional posts.